Latest filing published 18 Sept 2026 for Vivos Therapeutics, Inc., €44k.
Filing timeline
BuySaleInsider track record
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Ronald Kirk Huntsman: trading record in brief
Ronald Kirk Huntsman is a declared insider of Vivos Therapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). We count 14 filings; the first trade dates from 11 December 2020 and the latest from 30 June 2026.
No open-market sale appears; the market trades are 13 purchases worth €108k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €6,795. Of 11 purchases, 1 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 18 September 2026, reports a transaction of €44k in Vivos Therapeutics, Inc. The last insider purchase was made public on 20 June 2023, 1,237 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ronald Kirk Huntsman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 85,910 shares@ US$0.582Preferred StockSEC:0001493152-26-043383:0
- 14,000 shares@ US$0.535.1% of flowCommon StockSEC:0001493152-23-021910:0Canonical exit: 18 Sept 2023 (T+90)
- 21 shares@ US$0.500.0% of flowCommon StockSEC:0001493152-23-021751:0Canonical exit: 13 Sept 2023 (T+90)
- 10,000 shares@ US$0.493.4% of flowCommon StockSEC:0001493152-23-021525:0Canonical exit: 12 Sept 2023 (T+90)
- 20,000 shares@ US$0.507.1% of flowCommon StockSEC:0001493152-22-036727:0Canonical exit: 23 Mar 2023 (T+90)
- 8,000 shares@ US$2.0317.9% of flowCommon StockSEC:0001493152-22-015773:0Canonical exit: 29 Aug 2022 (T+90)
- 5,000 shares@ US$4.3121.7% of flowCommon StockSEC:0001493152-21-023354:0Canonical exit: 20 Dec 2021 (T+90)
- 5,000 shares@ US$3.0015.1% of flowCommon StockSEC:0001493152-21-020536:0Canonical exit: 15 Nov 2021 (T+90)
- 4,000 shares@ US$5.3820.8% of flowCommon StockSEC:0001493152-21-012901:0Canonical exit: 23 Aug 2021 (T+90)
9 of 9 declarations